49 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
33
3-oxadiazolyl substituted pyrazolo[1,5,a]pyrimidines for ROS1, NTRK, and ALK mediated diseases
Tyk Medicines
104
NEUROPEPTIDE Y1 RECEPTOR (NPY1R) TARGETED THERAPEUTICS AND USES THEREOF
Radionetics Oncology
6
Pyrimidine Heterocyclic Compound, Preparation Method Thereof and use Thereof in Medicine
Insilico Medicine IP
108
NITROGEN-CONTAINING POLYCYCLIC FUSED RING COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, PREPARATION METHOD THEREFOR, AND USE THEREOF
Applied Pharmaceutical Science
172
AMINOHETEROARYL KINASE INHIBITORS
Anrui Biomedical Technology (Guangzhou) Co.
140
Compounds for inhibiting TNIK and medical uses thereof
Korea Research Institute of Chemical Technology
80
CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer
Amgen
708
Substituted carboxamides as inhibitors of WDR5 protein-protein binding
Propellon Therapeutics
23
Compositions and methods for treating KIT- and PDGFRA-mediated diseases
Blueprint Medicines
1
Polymorphs of N-[(R)-1-[(S)-1-(4-aminomethyl-benzylcarbamoyl)-2-phenyl-ethylcarbamoyl]-2-(4-ethoxy-phenyl)-ethyl]-benzamide hydrochloride
Kalvista Pharmaceuticals
11
Carbonic anhydrase inhibitors: in vitro inhibition of a isoforms (hCA I, hCA II, bCA III, hCA IV) by flavonoids.
Ondokuz Mayis University
64
Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors
Vtv Therapeutics
19
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
Merck Sharp & Dohme
20
Discovery of isoalloxazine derivatives as a new class of potential anti-Alzheimer agents and their synthesis.
The M. S. University of Baroda
36
Substituted spiro[cycloalkyl-1,3′-indo]-2′(1′H)-one derivatives and their use as P38 mitogen-activated kinase inhibitors
Almirall
11
Identification of a Novel Series of Potent TrkA Receptor Tyrosine Kinase Inhibitors
Methylgene
21
Monoamine oxidase inhibition by C4-substituted phthalonitriles.
North-West University
8
Pharmacological characterization of a novel nonpeptide antagonist radioligand, (+/-)-N-[2-methyl-4-methoxyphenyl]-1-(1-(methoxymethyl) propyl)-6-methyl-1H-1,2,3-triazolo[4,5-c]pyridin-4-amine ([3H]SN003) for corticotropin-releasing factor1 receptors.
Bristol Myers Squibb
15
Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior.
Bayer
24
Characterization of 5-hydroxytryptamine1B receptors in rat spinal cord via [125I]iodocyanopindolol binding and inhibition of [3H]-5-hydroxytryptamine release.
University of Texas
30
A novel class of carbonic anhydrase inhibitors: glycoconjugate benzene sulfonamides prepared by "click-tailing".
Griffith University
12
Synthesis and pharmacological evaluation of huprine-tacrine heterodimers: subnanomolar dual binding site acetylcholinesterase inhibitors.
Universitat De Barcelona
25
Dual-site binding of bivalent 4-aminopyridine- and 4-aminoquinoline-based AChE inhibitors: contribution of the hydrophobic alkylene tether to monomer and dimer affinities.
Hong Kong University of Science and Technology